Skip to content

Pasadena Star News

64°F
Friday, May 1st 2026

e-Edition

Trending:

Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KALA BIO, Inc. - Common Stock (NQ:KALA)

0.4293 -0.0707 (-14.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 29,360,976
Open 0.5300
Bid (Size) 0.4291 (100)
Ask (Size) 0.4306 (600)
Prev. Close 0.5000
Today's Range 0.4104 - 0.5380
52wk Range 0.4010 - 123.00
Shares Outstanding 7,432,925
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform with Approximately $48 Million in Sales Since Inception
Key HighlightsTarget generated approximately $12.7 million in revenue for the trailing twelve months ended August 2026 (unaudited, as provided by... 
Via Newsfile
Topics Artificial Intelligence
News headline image
Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products
Agreement would expand the companies' genetic testing collaboration beyond ophthalmology to a selected suite of genomic testing products through an additional U.S. reseller channel 
From KALA BIO, Inc.
Via GlobeNewswire

Performance

YTD
-98.6%
-98.6%
1 Month
-36.2%
-36.2%
3 Month
-75.2%
-75.2%
6 Month
-95.0%
-95.0%
1 Year
-99.6%
-99.6%

More News

Read More
News headline image
KALA BIO Adds Healthcare Operator Yenvy Truong to Advisory Team
From KALA BIO, Inc.
Via GlobeNewswire
On Thursday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
News headline image
Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
From KALA BIO, Inc.
Via GlobeNewswire
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
Tuesday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
From KALA BIO, Inc.
Via GlobeNewswire
InvestorNewsBreaks – KALA BIO, Inc. (NASDAQ: KALA) Implements 1-For-50 Reverse Stock Split
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
KALA BIO Announces Reverse Stock Split
From KALA BIO, Inc.
Via GlobeNewswire
News headline image
Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine
From KALA BIO, Inc.
Via GlobeNewswire
News headline image
$9.1 Billion Mesenchymal Stem Cell Market by 2031 to be Focused on by New Senior Scientific Advisor for KALA BIO, Inc. (Nasdaq: KALA)
Via Get News
Topics Artificial Intelligence Intellectual Property
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities
From KALA BIO, Inc.
Via GlobeNewswire
News headline image
Bionic Intelligence Research Agent Now Commercially Live for Secure, Scalable, Autonomous Solutions in Global Biotech and Pharma Industries: KALA BIO, Inc. (Nasdaq: KALA)
Via Get News
Topics Artificial Intelligence Intellectual Property
News headline image
KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live
From KALA BIO, Inc.
Via GlobeNewswire
News headline image
$180 Billion AI Healthcare Emerging Sector Highlighted by Red Light Holland’s Researgency.ai Platform for Biotech & Pharmaceutical Industry: KALA BIO, Inc. (Nasdaq: KALA)
Via Get News
Topics Artificial Intelligence Intellectual Property
News headline image
Red Light Holland Engages Kala Bio’s Researgency.AI Platform to Support Clinical Development of Filament’s Patented PEX010 Botanical Psilocybin Drug Candidate
From KALA BIO, Inc.
Via GlobeNewswire
Which stocks have an unusual volume on Friday? ↗
Via Chartmill
Which stocks have an unusual volume on Thursday? ↗
Via Chartmill
These stocks are making the most noise in today's session. ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents
Via Newsfile
Topics Artificial Intelligence
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
Why Did KALA Stock Surge 70% In Pre-Market Today? ↗
Via Stocktwits
Topics Artificial Intelligence

Frequently Asked Questions

Is KALA BIO, Inc. - Common Stock publicly traded?
Yes, KALA BIO, Inc. - Common Stock is publicly traded.
What exchange does KALA BIO, Inc. - Common Stock trade on?
KALA BIO, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for KALA BIO, Inc. - Common Stock?
The ticker symbol for KALA BIO, Inc. - Common Stock is KALA on the Nasdaq Stock Market
What is the current price of KALA BIO, Inc. - Common Stock?
The current price of KALA BIO, Inc. - Common Stock is 0.4293
When was KALA BIO, Inc. - Common Stock last traded?
The last trade of KALA BIO, Inc. - Common Stock was at 09/30/26 04:00 PM ET
What is the market capitalization of KALA BIO, Inc. - Common Stock?
The market capitalization of KALA BIO, Inc. - Common Stock is 3.19M
How many shares of KALA BIO, Inc. - Common Stock are outstanding?
KALA BIO, Inc. - Common Stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.